• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

    5/26/23 8:50:26 AM ET
    $ANGN
    $BMR
    $EFTR
    $ELEV
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ANGN alert in real time by email

    Gainers

    • Oncorus, Inc. (NASDAQ:ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.
    • eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) shares surged 67.6% to $0.8866 in pre-market trading as the company reported data updates from Phase 2 expansion cohorts evaluating zotatifin in patients with ER+ metastatic breast cancer at the ASCO 2023 Annual Meeting.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) gained 45.4% to $1.73 in pre-market trading after dropping 8% on Thursday. Shuttle Pharmaceuticals was recently granted U.S. patent #11654157: Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation.
    • Arcus Biosciences, Inc. (NYSE:RCUS) gained 26.5% to $22.14 in pre-market trading. Arcus Biosciences announced new employment inducement grants.
    • Harbor Custom Development, Inc. (NASDAQ:HCDI) shares gained 24.1% to $4.64 in pre-market trading. Harbor Custom Development recently issued an update on the Company’s six multi-family projects.
    • Elevation Oncology, Inc. (NASDAQ:ELEV) shares gained 21.2% to $3.65 in pre-market trading after adding over 15% on Thursday.
    • Marvell Technology, Inc. (NASDAQ:MRVL) rose 15.9% to $57.34 in pre-market trading after the company reported strong Q1 results and said it expects AI revenue to at least double in 2024.
    • PDS Biotechnology Corporation (NASDAQ:PDSB) rose 15.5% to $7.76 in pre-market trading. PDS Biotechnology announced promising interim data from the VERSATILE-002 Phase 2 clinical trial.
    • Angion Biomedica Corp. (NASDAQ:ANGN) shares climbed 13% to $0.9601 in pre-market trading after gaining around 4% on Thursday.
    • The Gap, Inc. (NYSE:GPS) shares rose 11.8% to $8.30 in pre-market trading after the retailer turned in a profitable quarter on an adjusted basis, despite analysts forecasting a significant loss.

    Losers

    • SunCar Technology Group Inc. (NASDAQ:SDA) fell 24.5% to $11.37 in pre-market amid continued volatility following the recent completion of the company's combination with Goldenbridge Acquisition to become a publicly-traded company.
    • Beamr Imaging Ltd. (NASDAQ:BMR) shares dropped 19.1% to $4.01 in pre-market trading. Beamr Imaging shares jumped 125% on Thursday after NVIDIA announced the release of NVENC Video Codec SDK 12.1 showcasing the integration with Beamr CABR.
    • Tilray Brands, Inc. (NASDAQ:TLRY) fell 18.6% to $1.92 in pre-market trading after the company raised $150 million via unsecured convertible senior notes offering.
    • Wearable Devices Ltd. (NASDAQ:WLDS) fell 17.7% to $1.16 in pre-market trading. Wearable Devices shares jumped over 222% on Thursday after the company announced its Mudra Band for Apple Watch is available for preorder.
    • Peraso Inc. (NASDAQ:PRSO) fell 17.4% to $0.4050 in pre-market trading after jumping 21% on Thursday.
    • Nano Labs Ltd (NASDAQ:NA) fell 14.7% to $2.02 in pre-market trading after climbing over 69% on Thursday.
    • Infobird Co., Ltd (NASDAQ:IFBD) shares dropped 12.4% to $1.20 in pre-market trading after climbing 23% on Thursday.
    • Evoke Pharma, Inc. (NASDAQ:EVOK) fell 11.2% to $1.66 in pre-market trading. Evoke Pharma recently posted a wider-than-expected quarterly loss.
    • Lizhi Inc. (NASDAQ:LIZI) shares fell 9.8% to $0.74 in pre-market trading. Lizhi shares jumped 17% on Thursday after releasing first-quarter results.
    • X Financial (NYSE:XYF) fell 8.7% to $3.25 in pre-market trading after jumping around 15% on Thursday.

     

    Now Read This: Investor Sentiment Improves Following Strong Results From Nvidia

    Get the next $ANGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANGN
    $BMR
    $EFTR
    $ELEV

    CompanyDatePrice TargetRatingAnalyst
    Marvell Technology Inc.
    $MRVL
    3/6/2026$130.00Hold → Buy
    The Benchmark Company
    Marvell Technology Inc.
    $MRVL
    3/6/2026$110.00Neutral → Buy
    BofA Securities
    Arcus Biosciences Inc.
    $RCUS
    2/12/2026$23.00Overweight → Equal Weight
    Wells Fargo
    Tilray Brands Inc.
    $TLRY
    1/27/2026Hold
    Canaccord Genuity
    Marvell Technology Inc.
    $MRVL
    1/15/2026$105.00Outperform
    RBC Capital Mkts
    Arcus Biosciences Inc.
    $RCUS
    1/13/2026$28.00Neutral → Buy
    Goldman
    Arcus Biosciences Inc.
    $RCUS
    1/8/2026$20.00Overweight → Equal-Weight
    Morgan Stanley
    Marvell Technology Inc.
    $MRVL
    1/5/2026$135.00Hold → Buy
    Melius
    More analyst ratings

    $ANGN
    $BMR
    $EFTR
    $ELEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Marvell upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Marvell from Hold to Buy and set a new price target of $130.00

    3/6/26 8:19:48 AM ET
    $MRVL
    Semiconductors
    Technology

    Marvell upgraded by BofA Securities with a new price target

    BofA Securities upgraded Marvell from Neutral to Buy and set a new price target of $110.00

    3/6/26 8:19:38 AM ET
    $MRVL
    Semiconductors
    Technology

    Arcus Biosciences downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Arcus Biosciences from Overweight to Equal Weight and set a new price target of $23.00

    2/12/26 7:22:07 AM ET
    $RCUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANGN
    $BMR
    $EFTR
    $ELEV
    SEC Filings

    View All

    SEC Form 8-K filed by Shuttle Pharmaceuticals Holdings Inc.

    8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)

    3/10/26 5:00:43 PM ET
    $SHPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Shuttle Pharmaceuticals Holdings Inc.

    424B3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)

    3/9/26 8:00:18 AM ET
    $SHPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Wearable Devices Ltd.

    6-K - Wearable Devices Ltd. (0001887673) (Filer)

    3/6/26 4:10:07 PM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    $ANGN
    $BMR
    $EFTR
    $ELEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arcus Biosciences Announces New Employment Inducement Grants

    Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced that the Compensation Committee of the Company's Board of Directors granted two new employees options to purchase a total of 17,050 shares of the Company's common stock at an exercise price per share of $23.43, which was the closing price on March 9, 2026, and restricted stock units to acquire a total of 8,550 shares of the Company's common stock. The equity awards were granted pursuant to the Company's 2020 Inducement Plan, which was approved by the Co

    3/9/26 4:35:00 PM ET
    $RCUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region

    Acquisition Includes BrewDog's Profitable Australian Operations Including Brisbane Brewery and Two Flagship Bars Transaction Positions Tilray to Scale BrewDog Across Australia's National Retail and Grocery Channels and Introduce Broader Beverage Portfolio Across Asia-Pacific NEW YORK and BRISBANE, Australia, March 09, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the completion of the acquisition of BrewDog Brewing Australia Pty Ltd., including BrewDog's Australian brewing and pr

    3/9/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Wearable Devices Ltd. Announces 1-for-3 Reverse Stock Split

    Strategic Action Aimed at Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Protecting Continued Listing Status YOKNEAM ILLIT, ISRAEL, March 06, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the "Company" or "Wearable Devices") (NASDAQ:WLDS, WLDSW)), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced that it intends to effect a one-for-three reverse split (the "Reverse Share Split") of the Company's ordinary shares, no par value per share, (the "Ordinary Shares") and the Company's tradable warrants (the "Warrants"). The Ordinary Shares and Warrants will continue to trade on the Nasdaq Capita

    3/6/26 4:05:00 PM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    $ANGN
    $BMR
    $EFTR
    $ELEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Meintjes Willem A bought $265,302 worth of shares (3,400 units at $78.03), increasing direct ownership by 3% to 132,159 units (SEC Form 4)

    4 - Marvell Technology, Inc. (0001835632) (Issuer)

    9/25/25 11:25:59 AM ET
    $MRVL
    Semiconductors
    Technology

    President, Data Center Group Bharathi Sandeep bought $265,302 worth of shares (3,400 units at $78.03), increasing direct ownership by 5% to 73,392 units (SEC Form 4)

    4 - Marvell Technology, Inc. (0001835632) (Issuer)

    9/25/25 11:24:19 AM ET
    $MRVL
    Semiconductors
    Technology

    President and COO Koopmans Chris bought $530,604 worth of shares (6,800 units at $78.03) (SEC Form 4)

    4 - Marvell Technology, Inc. (0001835632) (Issuer)

    9/25/25 11:22:43 AM ET
    $MRVL
    Semiconductors
    Technology

    $ANGN
    $BMR
    $EFTR
    $ELEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Glover Stephen C.

    4 - PDS Biotechnology Corp (0001472091) (Issuer)

    3/3/26 6:47:21 PM ET
    $PDSB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by President/CEO Bedu-Addo Frank

    4 - PDS Biotechnology Corp (0001472091) (Issuer)

    3/3/26 6:47:33 PM ET
    $PDSB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Financial Officer Boesgaard Lars

    4 - PDS Biotechnology Corp (0001472091) (Issuer)

    3/3/26 6:47:29 PM ET
    $PDSB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANGN
    $BMR
    $EFTR
    $ELEV
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIMOTI

    Submission status for EVOKE PHARMA INC's drug GIMOTI (SUPPL-1) with active ingredient METOCLOPRAMIDE HYDROCHLORIDE has changed to 'Approval' on 01/14/2021. Application Category: NDA, Application Number: 209388, Application Classification: Labeling

    1/15/21 5:10:35 AM ET
    $EVOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANGN
    $BMR
    $EFTR
    $ELEV
    Financials

    Live finance-specific insights

    View All

    Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region

    Acquisition Includes BrewDog's Profitable Australian Operations Including Brisbane Brewery and Two Flagship Bars Transaction Positions Tilray to Scale BrewDog Across Australia's National Retail and Grocery Channels and Introduce Broader Beverage Portfolio Across Asia-Pacific NEW YORK and BRISBANE, Australia, March 09, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the completion of the acquisition of BrewDog Brewing Australia Pty Ltd., including BrewDog's Australian brewing and pr

    3/9/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Marvell Technology, Inc. Reports Fourth Quarter and Fiscal Year 2026 Financial Results

    Q4 Net Revenue: $2.219 billion, a new record, grew by 22% year-on-year Q4 Gross Margin: 51.7% GAAP gross margin; 59.0% non-GAAP gross margin Q4 Diluted income per share: $0.46 GAAP diluted income per share; $0.80 non-GAAP diluted income per share Marvell Technology, Inc. (NASDAQ:MRVL), a leader in data infrastructure semiconductor solutions, today reported financial results for the fourth fiscal quarter and fiscal year ended January 31, 2026. Net revenue for the fourth quarter of fiscal 2026 was $2.219 billion, $19.0 million above the mid-point of the Company's guidance provided on December 2, 2025. GAAP net income for the fourth quarter of fiscal 2026 was $396.1 million, or $0.

    3/5/26 4:05:00 PM ET
    $MRVL
    Semiconductors
    Technology

    Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform

    Accretive Acquisition of Select Assets Includes Global Brand, UK Brewing Operations and 11 Strategic Brewpubs  Expected to Generate ~$200 Million in Annual Net Revenue and ~$6 - $8 Million of Adjusted EBITDA in Fiscal 2027 Tilray's Global Consolidated Net Revenue Expected to Reach ~$1.2 Billion on an Annualized Basis1 Conference Call Scheduled for 12:30pm ET NEW YORK and LONDON, March 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today completed the acquisition of certain highly strategic

    3/2/26 10:17:01 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $ANGN
    $BMR
    $EFTR
    $ELEV
    Leadership Updates

    Live Leadership Updates

    View All

    Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

    BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery's full spirits collection across Illinois—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched Mountain Shot. Romano's strong presence in Illinois and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thr

    2/4/26 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Nano Labs Announces Results of Annual General Meeting of Shareholders

    HONG KONG, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (NASDAQ:NA) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure and product solution provider, today announced the results of the Company's Annual General Meeting ("AGM") held at 10 A.M. on December 30, 2025, Beijing time (9 P.M., December 29, 2025, U.S. Eastern time). The proposals submitted for shareholder approval at the AGM have been approved. Specifically, the shareholders have passed the following resolutions: 1)  to authorize (a) a share consolidation of every ten shares with a par value of US$0.002 each in the Company's issued and unissued share capital into one share with a par value of US$0.02 (the "Sh

    12/30/25 8:00:00 AM ET
    $NA
    Semiconductors
    Technology

    Nano Labs Announces Annual General Meeting

    HONG KONG, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (NASDAQ:NA) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure and product solution provider, today announced that it will hold its 2025 Annual General Meeting of Shareholders (the "2025 Annual Meeting") at 10 A.M. on December 30, 2025, Beijing time (9 P.M. on December 29, 2025, U.S. Eastern time) in 12F, China Yuangu Hanggang Technology Building, 509 Qianjiang Road, Shangcheng District, Hangzhou, Zhejiang, 310000, People's Republic of China. The Company has established the close of business on December 4, 2025, Eastern time (the "Record Date"), as the record date for determining shareholders entitled to notice

    12/2/25 7:00:00 AM ET
    $NA
    Semiconductors
    Technology

    $ANGN
    $BMR
    $EFTR
    $ELEV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arcus Biosciences Inc.

    SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)

    12/17/24 9:52:58 PM ET
    $RCUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Elevation Oncology Inc.

    SC 13G/A - Elevation Oncology, Inc. (0001783032) (Subject)

    11/14/24 7:50:19 PM ET
    $ELEV
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Elevation Oncology Inc.

    SC 13G/A - Elevation Oncology, Inc. (0001783032) (Subject)

    11/14/24 7:05:59 PM ET
    $ELEV
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care